FDA approves at-home HIV test

  • Thu, 07/05/2012 - 2:21pm

In the event you’ve put yourself at risk for HIV infection – or just want to take responsible precautions – but are too embarrassed to visit a clinic and get tested, the U.S.

FDA, companies to study metal-on-metal implant effects

  • Mon, 07/02/2012 - 4:06pm

The FDA recently asked a panel of experts to recommend guidelines for monitoring over 500,000 patients with metal-on-metal hip replacements.

FDA approves Actavis' generic ADHD drug

  • Tue, 06/26/2012 - 3:34pm

The U.S. Food and Drug Administration recently created competition for Adderall XR manufacturer Shire PLC by approving another company’s generic form of the ADHD medication.

FDA Reports Metal-on-Metal Hip Implant Statistics

  • Fri, 06/22/2012 - 12:54pm

The Food and Drug Administration has concerns regarding metal-on-metal hip implants due to the myriad of negative effects they have had on people in the US in the past decade.

Fentanyl Patch Fatalities

  • Mon, 06/18/2012 - 2:24pm

In the past 15 years, 26 children have suffered accidental exposure to fentanyl patches, according to the FDA and the Institute for Safe Medicine Practices.

FDA OKs new meningitis vaccine for babies

  • Fri, 06/15/2012 - 3:16pm

The U.S.

FDA approves breakthrough breast cancer drug

  • Mon, 06/11/2012 - 2:57pm

In an unprecedented breakthrough in breast cancer research, the FDA approved a new drug that should improve on the treatment of one of the most deadly forms of breast cancer to date, HER2-positive.

Takeda Pharmaceuticals struggles to gain FDA approval

Takeda Pharmaceuticals determined to gain FDA drug approval

  • Mon, 05/14/2012 - 1:48pm

In a country bulging with 23 million people with type 2 diabetes, Avandia and its successor, Actos, were once blockbuster drugs in the U.S.